Condition: Migraine · Sponsor: Pfizer
The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to \<18 years with episodic migraine.
This description comes directly from the study's public registry record.
Pfizer Pfizer CT.gov Call Center · 1-800-718-1021 · ClinicalTrials.gov_Inquiries@pfizer.com
Always discuss trial participation with your own doctor first.
| The Belinga Clinic | Fort Smith, Arkansas, United States | Active Not Recruiting |
| Advanced Investigative Medicine, Inc. | Hawthorne, California, United States | Recruiting |
| Velocity Clinical Research San Diego | La Mesa, California, United States | Active Not Recruiting |
| Colorado Springs Neurological Associates | Colorado Springs, Colorado, United States | Active Not Recruiting |
| Advanced Neurosciences Research, LLC | Fort Collins, Colorado, United States | Terminated |
| Velocity Clinical Research, Washington DC | Washington D.C., District of Columbia, United States | Recruiting |
| Accel Research Sites Network - Edgewater Clinical Research Unit | Edgewater, Florida, United States | Active Not Recruiting |
| Direct Helpers Research Center | Hialeah, Florida, United States | Recruiting |
| New Med Research, Inc | Hollywood, Florida, United States | Terminated |
| Complete Health Research | Ormond Beach, Florida, United States | Active Not Recruiting |
| D&H Tamarac Research Center LLC | Tamarac, Florida, United States | Recruiting |
| Santos Research Center, CORP | Tampa, Florida, United States | Recruiting |
+ 78 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05156398